Type I strain RH79, RH-Δku80Δhxgprt (RHΔku80)80, GT181, Type II ME4982, NTE82, Pru-Δku80Δhxgprt(BSG-4) (Pru-GFP)42, Pru-Δhxgprt tdTomato (Pru-tdTomato)83 and Type III NED84, VEG (85, provided by G. Schares), were maintained in vitro in HFF monolayers grown in DMEM supplemented with 25 mM glucose, 4 mM l-glutamine, 1 mM sodium pyruvate, 100 U/ml penicillin, 100 μg/ml streptomycin and 1% heat-inactivated FBS (tachyzoite medium). Freshly egressed parasites were passaged by transfer to new HFF monolayers.
Differentiation of tachyzoites into tissue cysts was facilitated by CO2 depletion at pH 7.4 if not otherwise indicated. To avoid acidification, the medium was changed to low glucose (5 mM), 50 mM HEPES (Sigma-Aldrich) buffered RPMI 1640 medium (Gibco) supplemented with 4 mM l-glutamine, 100 U/ml penicillin, 100 µg/ml streptomycin, 2% HOS, and 10 µg/ml human insulin, 5 µg/ml human holo-transferrin and 1.7 ng/µl sodium selenite (bradyzoite medium). The cells were incubated at 37 °C and ambient CO2 levels. Medium was changed every two days and cells were washed once per week with PBS. The day after infection, infected monolayers were washed with prewarmed PBS to remove non-invaded parasites. Medium was changed every second day and bradyzoite cultures were washed with PBS once a week. For assays involving plate reader-based fluorescence measurements, phenol red was omitted from the medium.
Do you have any questions about this protocol?
Post your question to gather feedback from the community. We will also invite the authors of this article to respond.